Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. (Q46966641)
scientific article published in March 2006
Language:
Current Data About Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.
(P31) (Q13442814)
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(P50) (Q18389345)
(P1545) 9
(P1932) Edith A Perez
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(Q96186734)
(P1545) 2
(P1932) Vera J Suman
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(Q89668737)
(P1545) 1
(P1932) James N Ingle
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(P304) 1052-1056
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(P407) (Q1860)

(P433) 7
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(P478) 24
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(P577) Wednesday, March 1, 2006
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(P1433) (Q400292)
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(P1476) "Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032." (language: en)
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

(P2093) Kendrith M Rowland
(P1545) 3
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

Deepu Mirchandani
(P1545) 4
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

Albert M Bernath
(P1545) 5
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

John K Camoriano
(P1545) 6
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

Paul A S Fishkin
(P1545) 7
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

Daniel A Nikcevich
(P1545) 8
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

North Central Cancer Treatment Group Trial N0032
(P1545) 10
(P248)
(P698) 16505423
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505423

other details
description scientific article published in March 2006

External Links
(P356) 10.1200/JCO.2005.04.1053
(P698) 16505423